Oxford Biomedica Plc New (OXBDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,549 | -51,145 | -45,102 | -234,509 | -65,540 |
| Depreciation Amortization | 14,957 | 24,268 | 14,491 | 35,712 | 18,575 |
| Accounts receivable | -10,523 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -4,432 | N/A | N/A | N/A | N/A |
| Other Working Capital | 7,748 | -37,206 | -21,721 | 21,715 | 31,197 |
| Other Operating Activity | 25,920 | 9,257 | 2,859 | 141,610 | 8,989 |
| Operating Cash Flow | $4,121 | $-54,826 | $-49,473 | $-35,472 | $-6,779 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,493 | -8,111 | -5,272 | -1,794 | -543 |
| Net Acquisitions | N/A | 9,743 | 11,364 | 0 | N/A |
| Other Investing Activity | 1,222 | 4,462 | 3,104 | 5,284 | 2,775 |
| Investing Cash Flow | $-271 | $6,094 | $9,196 | $3,490 | $2,232 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -326 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 107 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -11,307 | 3,147 | 12,347 | -15,801 | -8,631 |
| Financing Cash Flow | $-11,526 | $3,147 | $12,347 | $-15,801 | $-8,631 |
| Exchange Rate Effect | -13 | -1,017 | -223 | 1,051 | -1,667 |
| Beginning Cash Position | 68,850 | 112,231 | 130,900 | 175,744 | 176,903 |
| End Cash Position | 61,161 | 65,629 | 102,746 | 129,012 | 162,059 |
| Net Cash Flow | $-7,689 | $-46,602 | $-28,154 | $-46,732 | $-14,844 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,121 | -54,826 | -49,473 | -35,472 | -6,779 |
| Capital Expenditure | -1,713 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 2,408 | -54,826 | -49,473 | -35,472 | -6,779 |